Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
Top 10 MS news stories of 2024. The team at Multiple Sclerosis News Today has brought our audience the latest news about treatments, scientific research, and clinical trials in multiple …
Top 10 MS stories of 2023 - Multiple Sclerosis News Today
Jan 2, 2024 · Throughout 2023, Multiple Sclerosis News Today brought consistent coverage to our readers of the latest scientific research, developments in treatment, and clinical trials for …
ECTRIMS 2024: Tolebrutinib may target smoldering inflammation
Sep 23, 2024 · The findings were presented in a pair of Sanofi-sponsored late-breaking presentations at the European Committee for Treatment and Research in Multiple Sclerosis …
1-year fenebrutinib inhibits nearly all MS signs in relapsing MS trial
Sep 6, 2024 · News; 1-year fenebrutinib curbs nearly all disease activity in relapsing MS trial ... to present the data in more detail at the upcoming Congress of the European Committee for …
ACTRIMS 2024 - Multiple Sclerosis News Today
Multiple Sclerosis News Today is providing coverage of the ninth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024 Feb. 29-March 2 in …
AAN 2024: In MS study, long-term CNM-Au8 shows myelin, nerve …
Apr 18, 2024 · Note: The Multiple Sclerosis News Today team is providing coverage of the American Academy of Neurology (AAN) 2024 Annual Meeting April 13-18. Go here to see the …
About Us - Multiple Sclerosis News Today
Multiple Sclerosis News Today is a digital platform intended to provide the multiple sclerosis (MS) community with the most recent news and information on MS, as well as first-hand community ...
FDA OKs Phase 2 clinical trial of KYV-101 for progressive MS
Jan 5, 2024 · News; FDA OKs Phase 2 clinical trial of KYV-101 for progressive MS ... The trial page lists a single study site at the Stanford Multiple Sclerosis Center, in California. The KYSA …
Vidofludimus calcium trials continue as planned after panel review
Oct 23, 2024 · The identically designed ENSURE-1 (NCT05134441) and ENSURE-2 (NCT05201638) trials are each expected to enroll around 1,050 adults with active, relapsing …
The MS Wire – Ed Tobias | Multiple Sclerosis News Today
Dec 8, 2023 · MS news notes: Vumerity, herpes virus, caregivers. Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week.